IRLAB Therapeutics AB (OSTO:IRLAB A) Price-to-Tangible-Book : 26.96 (As of May. 28, 2024)

View and export this data going back to 2017. Start your Free Trial

What is IRLAB Therapeutics AB Price-to-Tangible-Book?

As of today (2024-05-28), IRLAB Therapeutics AB's share price is kr15.50. IRLAB Therapeutics AB's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was kr0.58. Hence, IRLAB Therapeutics AB's Price to Tangible Book Ratio of today is 26.96.

The historical rank and industry rank for IRLAB Therapeutics AB's Price-to-Tangible-Book or its related term are showing as below:

OSTO:IRLAB A' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3.03 Med: 8.21 Max: 44.92
Current: 26.72

During the past 11 years, IRLAB Therapeutics AB's highest Price to Tangible Book Ratio was 44.92. The lowest was 3.03. And the median was 8.21.

OSTO:IRLAB A's Price-to-Tangible-Book is ranked worse than
96.56% of 1221 companies
in the Biotechnology industry
Industry Median: 2.79 vs OSTO:IRLAB A: 26.72

A closely related ratio is called PB Ratio. As of today, IRLAB Therapeutics AB's share price is kr15.50. IRLAB Therapeutics AB's Book Value per Sharefor the quarter that ended in Mar. 2024 was kr1.48. Hence, IRLAB Therapeutics AB's P/B Ratio of today is 10.49.

IRLAB Therapeutics AB Price-to-Tangible-Book Historical Data

The historical data trend for IRLAB Therapeutics AB's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IRLAB Therapeutics AB Price-to-Tangible-Book Chart

IRLAB Therapeutics AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

15.85

7.66

6.38

8.14

5.65

IRLAB Therapeutics AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Tangible-Book	Get a 7-Day Free Trial															3.12	3.22	3.79	5.65	27.13

Competitive Comparison of IRLAB Therapeutics AB's Price-to-Tangible-Book

For the Biotechnology subindustry, IRLAB Therapeutics AB's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IRLAB Therapeutics AB's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IRLAB Therapeutics AB's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where IRLAB Therapeutics AB's Price-to-Tangible-Book falls into.

IRLAB Therapeutics AB Price-to-Tangible-Book Calculation

IRLAB Therapeutics AB's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2024 )
	=	15.50	/	0.575
	=	26.96

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

IRLAB Therapeutics AB Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of IRLAB Therapeutics AB's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

IRLAB Therapeutics AB (OSTO:IRLAB A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IRLAB Therapeutics AB (OSTO:IRLAB A) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

6IRA:Germany

Address

Arvid Wallgren Backe 20, Goteborg, SWE, 413 46

Website

https://www.irlab.se

IRLAB Therapeutics AB is a drug discovery and development company providing novel treatments for disorders of the brain. The company focuses on innovative treatments and quality of life for patients with neurological and psychiatric illnesses. It is engaged in programs targeting core dysfunctions in Parkinson's disease and dementias. In addition, it is also involved in the clinical development of novel compounds which aims at offering improved clinical benefit for patients with Parkinson's disease. The company's current clinical candidates, mesdopetam (IRL790) and pirepemat (IRL752), both of which have successfully gone through Phase I safety and Phase IIa efficacy proof-of-concept studies, are now in Phase IIb trials.

IRLAB Therapeutics AB (OSTO:IRLAB A) Headlines

No Headlines